Revisiting FDA Approval of Aducanumab

被引:128
作者
Alexander, G. Caleb [1 ,2 ]
Knopman, David S. [3 ]
Emerson, Scott S. [4 ]
Ovbiagele, Bruce [5 ]
Kryscio, Richard J. [6 ,7 ]
Perlmutter, Joel S. [8 ,9 ,10 ,11 ,12 ]
Kesselheim, Aaron S. [13 ,14 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Drug Safety & Effect, Baltimore, MD 21205 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[3] Mayo Clin, Dept Neurol, Rochester, MN USA
[4] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[5] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA
[6] Univ Kentucky, Bin Zhang Dept Stat, Lexington, KY USA
[7] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY USA
[8] Washington Univ, Dept Neurol, St Louis, MO USA
[9] Washington Univ, Dept Radiol, St Louis, MO USA
[10] Washington Univ, Dept Neurosci, St Louis, MO 63110 USA
[11] Washington Univ, Dept Phys Therapy, St Louis, MO 63110 USA
[12] Washington Univ, Dept Occupat Therapy, St Louis, MO 63110 USA
[13] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
[14] Harvard Med Sch, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
关键词
D O I
10.1056/NEJMp2110468
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:769 / 771
页数:3
相关论文
共 5 条
[1]  
[Anonymous], 2020, PER CENTR NERV SYST
[2]  
[Anonymous], Combined FDA and Biogen briefing information for the November 6, 2020 meeting of the Peripheral and Central Nervous System Drugs Advisory Committee
[3]  
[Anonymous], SURR ENDP RES DRUG B
[4]  
[Anonymous], TRANSCR NOV 6 2020 M
[5]   Donanemab in Early Alzheimer's Disease [J].
Mintun, Mark A. ;
Lo, Albert C. ;
Evans, Cynthia Duggan ;
Wessels, Alette M. ;
Ardayfio, Paul A. ;
Andersen, Scott W. ;
Shcherbinin, Sergey ;
Sparks, JonDavid ;
Sims, John R. ;
Brys, Miroslaw ;
Apostolova, Liana G. ;
Salloway, Stephen P. ;
Skovronsky, Daniel M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (18) :1691-1704